Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Veteran withdrew all pending claims and appeals, effective December 11, 2020.

The Board denied the veteran's claims for increased ratings for bilateral pes cavus, left wrist tenosynovitis, neck sprain with cervicalgia and cervical spondylosis, nasal turbinate hypertrophy, and seborrheic dermatitis, tinea pedis, and onychomycosis of the nails.

The Board granted service connection for chronic fatigue syndrome, dermatitis, right shoulder strain, sinusitis, and reactive airway disease. The claims for PTSD, major depressive disorder, and panic attacks were remanded.

The Board of Veterans' Appeals denied the veteran's appeal for an increased rating in excess of 10 percent for service-connected acne.

The Board granted service connection for headaches and increased ratings for the low back, acquired psychiatric condition, and TDIU. The claims for increased ratings for left lower extremity radiculopathy, right lower extremity radiculopathy, dermatitis, and special monthly compensation were denied.

The Board granted service connection for a cervical spine disorder but denied service connection for psoriasis, varicose veins, nodule on right thyroid, sinusitis, allergic rhinitis, and gynecological disorder.

The Board denied the veteran's claims for an increased rating for pseudofolliculitis barbae and service connection for tinea pedis, while remanding a claim for service connection for generalized anxiety disorder.

The Board denied service connection for pseudofolliculitis barbae as the evidence did not support a nexus between the condition and the Veteran's military service.

The Board granted a 60 percent rating for psoriatic dermatitis, a 30 percent rating for GERD with hiatal hernia and gastritis, and a 20 percent rating for left wrist carpal tunnel syndrome (CTS), but denied a compensable rating for hemorrhoids.

The Board remands the claims for a lumbar spine disability, left clavicle disability, scar of the left clavicle, left ankle disability, right ankle disability, pseudofolliculitis barbae (skin) disability, and total disability rating based on individual unemployability due to service-connected disabilities for further development.

The Board granted an initial rating of 10 percent from April 13, 2012 for bilateral tinea pedis.

The Board remands the claims for service connection for a back condition and an initial compensable disability rating for pseudofolliculitis barbae due to insufficient evidence.

The Board granted service connection for bilateral upper and lower extremity polyneuropathy, but remanded the claim for dermatitis.

The Board denied the veteran's claims for increased ratings and earlier effective dates, finding that the evidence did not support a compensable rating or an earlier effective date.

The Board remands the claims for service connection for chronic fatigue syndrome, COPD, eczema, and diarrhea due to inadequate VA examinations.

The Veteran's service-connected disabilities did not prevent him from performing the physical and mental acts required for substantially gainful employment prior to April 3, 2018. However, he is entitled to special monthly compensation based on housebound status from April 3, 2018 to May 4, 2022.

The Board remands the claim for service connection for pseudofolliculitis barbae (PFB) to obtain a new medical opinion regarding its etiology.

The Board granted service connection for tinea, actinic keratosis, and seborrheic dermatitis, denied an initial compensable rating for bilateral hearing loss, and granted a TDIU due to service-connected PTSD from January 10, 2008.

The Board denied service connection for colitis and a compensable rating for pseudofolliculitis barbae (PFB), but remanded the claim for obstructive sleep apnea (OSA) for further development.

The Board remands the claims for service connection for various disabilities, including skin disability, hypertension, depression as secondary to prostate cancer, ischemic heart disease and coronary artery disease, prostate cancer, diabetes mellitus type II, thoracic aorta disabilities, sexual dysfunction, prostatitis, and cardiomegaly, due to insufficient evidence.